|
Facebook
Twitter
Linkedin
|
Hansen Medical Showcases Enhancements to Its Flexible Robotic Platform at Heart Rhythm 2009
| Company News - Hansen Medical |
Hansen Medical, Inc. will showcase advancements to its Sensei(R) Robotic Catheter System for electrophysiology (EP) procedures at Heart Rhythm 2009
Booth # 1267 - Hansen Medical, Inc. (NASDAQ: HNSN) will showcase advancements to its Sensei(R) Robotic Catheter System for electrophysiology (EP) procedures at Heart Rhythm 2009, the Heart Rhythm Society's 30th Annual Scientific Sessions in Boston, May 13 - 16. The company will demonstrate improvements in its user interface, catheter capabilities and design, and in imaging and mapping technology integration.
"It is our goal to continue to offer physicians preeminent technological solutions that provide confidence and accuracy during complex EP procedures," said Fred Moll, president and CEO of Hansen Medical. "We are very encouraged by the broad adoption of our technology worldwide with 65 systems shipped through March 31, 2009 and the significant volume of electrophysiology procedures performed using our flexible robotic platform."
The company will show its new tactile vibration feature for its IntelliSense(R) Fine Force Technology, which provides physicians with tactile feedback on proximal force for the first time with the Sensei system. As a result, physicians can now feel IntelliSense's force measurements through vibration of the Instinctive Motion Controller (IMC). In addition, physicians will continue to see a visual measure of force on the Sensei system's display monitor during EP procedures. With this new feature, physicians now have an improved tactile understanding of IntelliSense's measurements and force sensing during complex cardiac procedures. This advancement is important because a study suggests a link between the ability to measure force and the quality of electroanatomical maps(1).
"The new vibration feature for IntelliSense is an improvement to the Sensei system because I believe it allows me to concentrate on all the other aspects of the procedure while safely manipulating the catheter," said Laurence M. Epstein, M.D., chief, arrhythmia service, Cardiovascular Division, Brigham and Women's Hospital in Boston. "In addition, I have more confidence in the 3D surface maps I create because I can more easily adjust the force."
Hansen Medical will also showcase its CoHesion(TM) 3D Visualization Module, an integrated product that combines the 3D visualization of the EnSite(TM) electroanatomic mapping system from St. Jude Medical, with 3D navigation from the Sensei system. This integrated solution allows physicians the opportunity to navigate the robotic Artisan(TM) Control Catheter instinctively in St. Jude Medical's electroanatomic map. A European clinical study has demonstrated reductions in both procedure and fluoroscopy time when using the CoHesion product(2).
The Sensei system is built upon an open architecture design, which enables physicians to accurately deliver instinctive, flexible and stable catheter control during complex cardiac arrhythmia procedures. At the same time, physicians can choose and use their own preferred products because of this open architecture. Hansen Medical's commitment to open architecture allows for compatibility with a broad range of leading imaging companies including St. Jude Medical, Philips Healthcare and GE Healthcare. At Heart Rhythm 2009, Philips and Hansen Medical will reveal first results of their collaborative effort to further integrate the Xper Allura EP intervention lab with the Sensei system. Additionally, GE Healthcare will be featuring a Hansen Medical kiosk in the GE Healthcare booth.
Hansen Medical's technology is compatible with fluoroscopy, ultrasound, 3D surface map and patient electroanatomical data. The two main components that comprise the Sensei system are the Artisan catheter and the ergonomically designed, remotely placed workstation. The physician workstation is adaptable to existing EP lab suites and imaging technologies and can be placed away from the field of direct radiation.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei Robotic Catheter system, was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in electrophysiology (EP) procedures. Additional information can be found at www.hansenmedical.com.
Source: Hansen Medical
"It is our goal to continue to offer physicians preeminent technological solutions that provide confidence and accuracy during complex EP procedures," said Fred Moll, president and CEO of Hansen Medical. "We are very encouraged by the broad adoption of our technology worldwide with 65 systems shipped through March 31, 2009 and the significant volume of electrophysiology procedures performed using our flexible robotic platform."
The company will show its new tactile vibration feature for its IntelliSense(R) Fine Force Technology, which provides physicians with tactile feedback on proximal force for the first time with the Sensei system. As a result, physicians can now feel IntelliSense's force measurements through vibration of the Instinctive Motion Controller (IMC). In addition, physicians will continue to see a visual measure of force on the Sensei system's display monitor during EP procedures. With this new feature, physicians now have an improved tactile understanding of IntelliSense's measurements and force sensing during complex cardiac procedures. This advancement is important because a study suggests a link between the ability to measure force and the quality of electroanatomical maps(1).
"The new vibration feature for IntelliSense is an improvement to the Sensei system because I believe it allows me to concentrate on all the other aspects of the procedure while safely manipulating the catheter," said Laurence M. Epstein, M.D., chief, arrhythmia service, Cardiovascular Division, Brigham and Women's Hospital in Boston. "In addition, I have more confidence in the 3D surface maps I create because I can more easily adjust the force."
Hansen Medical will also showcase its CoHesion(TM) 3D Visualization Module, an integrated product that combines the 3D visualization of the EnSite(TM) electroanatomic mapping system from St. Jude Medical, with 3D navigation from the Sensei system. This integrated solution allows physicians the opportunity to navigate the robotic Artisan(TM) Control Catheter instinctively in St. Jude Medical's electroanatomic map. A European clinical study has demonstrated reductions in both procedure and fluoroscopy time when using the CoHesion product(2).
The Sensei system is built upon an open architecture design, which enables physicians to accurately deliver instinctive, flexible and stable catheter control during complex cardiac arrhythmia procedures. At the same time, physicians can choose and use their own preferred products because of this open architecture. Hansen Medical's commitment to open architecture allows for compatibility with a broad range of leading imaging companies including St. Jude Medical, Philips Healthcare and GE Healthcare. At Heart Rhythm 2009, Philips and Hansen Medical will reveal first results of their collaborative effort to further integrate the Xper Allura EP intervention lab with the Sensei system. Additionally, GE Healthcare will be featuring a Hansen Medical kiosk in the GE Healthcare booth.
Hansen Medical's technology is compatible with fluoroscopy, ultrasound, 3D surface map and patient electroanatomical data. The two main components that comprise the Sensei system are the Artisan catheter and the ergonomically designed, remotely placed workstation. The physician workstation is adaptable to existing EP lab suites and imaging technologies and can be placed away from the field of direct radiation.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei Robotic Catheter system, was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in electrophysiology (EP) procedures. Additional information can be found at www.hansenmedical.com.
Source: Hansen Medical











